Cargando…
Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians
BACKGROUND: The Middle East Respiratory Syndrome coronavirus (MERS-CoV) is an emerging respiratory pathogen with a high mortality rate and no specific treatments available to date. The purpose of this study was to determine the feasibility of conducting a randomized controlled trial (RCT) of convale...
Autores principales: | Arabi, Yaseen M., Al-Enezi, Farhan, Longuere, Kajsa-Stina, Balkhy, Hanan H., Al-Sultan, Mohamed, Al-Omari, Awad, Al-Hameed, Fahad M., Carson, Gail, Shindo, Nahoko, Fowler, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942900/ https://www.ncbi.nlm.nih.gov/pubmed/27405596 http://dx.doi.org/10.1186/s12871-016-0198-x |
Ejemplares similares
-
Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
Proceedings of the Middle East Respiratory Syndrome (MERS) Coronavirus research initiative workshop, September 9–10 2015 in Riyadh, KSA
por: Arabi, Yaseen M., et al.
Publicado: (2016) -
Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol
por: Arabi, Yaseen, et al.
Publicado: (2015) -
Critically ill healthcare workers with the middle east respiratory syndrome (MERS): A multicenter study
por: Shalhoub, Sarah, et al.
Publicado: (2018) -
The search for therapeutic options for Middle East Respiratory Syndrome (MERS)
por: Arabi, Yaseen M., et al.
Publicado: (2016)